Search by Drug Name or NDC

    NDC 00591-3330-01 Cyclobenzaprine Hydrochloride 7.5 mg/1 Details

    Cyclobenzaprine Hydrochloride 7.5 mg/1

    Cyclobenzaprine Hydrochloride is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is CYCLOBENZAPRINE HYDROCHLORIDE.

    Product Information

    NDC 00591-3330
    Product ID 0591-3330_13578288-1fa1-4710-91a0-6e3026156d91
    Associated GPIs 75100050100304
    GCN Sequence Number 062524
    GCN Sequence Number Description cyclobenzaprine HCl TABLET 7.5 MG ORAL
    HIC3 H6H
    HIC3 Description SKELETAL MUSCLE RELAXANTS
    GCN 98299
    HICL Sequence Number 001950
    HICL Sequence Number Description CYCLOBENZAPRINE HCL
    Brand/Generic Generic
    Proprietary Name Cyclobenzaprine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Cyclobenzaprine Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 7.5
    Active Ingredient Units mg/1
    Substance Name CYCLOBENZAPRINE HYDROCHLORIDE
    Labeler Name Actavis Pharma, Inc.
    Pharmaceutical Class Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA071611
    Listing Certified Through n/a

    Package

    NDC 00591-3330-01 (00591333001)

    NDC Package Code 0591-3330-01
    Billing NDC 00591333001
    Package 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-3330-01)
    Marketing Start Date 2006-02-03
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.40544
    Pricing Unit EA
    Effective Date 2022-11-23
    NDC Description CYCLOBENZAPRINE 7.5 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis